Reuters logo
BRIEF-Chongqing Zhifei Biological Products unit receives approval for drug clinical trial
October 10, 2017 / 4:44 AM / 7 days ago

BRIEF-Chongqing Zhifei Biological Products unit receives approval for drug clinical trial

Oct 10(Reuters) - Chongqing Zhifei Biological Products Co Ltd

* Says co’s wholly owned unit Beijing Luzhu Biopharmaceutical Co Ltd received approval for drug clinical trial for a kind of vaccine, from China Food and Drug Administration

Source text in Chinese: goo.gl/WbNha3

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below